EU: Commissie publiceert studie over impact van REACH

The European Commission published a study report carried out by an external team of consultants. The study on the impacts of REACH authorisation indicates that the system is achieving its objectives. The authorisation system is progressively promoting substitution of substances of very high concern (SVHCs) by available alternatives and reducing risks associated with the use of SVHCs.
The main benefits of authorisation: (1) REACH is one of the main drivers for substitution of SVHCs, from as early as the candidate listing stage; (2) Companies are improving risk management measures and operating conditions when substitution of SVHCs is not possible (ECHA, 12 december 2017).
Klik hier om het volledige nieuwsbericht te lezen.
Klik hier om het rapport van de studie te downloaden (5,49 MB).

Dit bericht is ook opgenomen in ons maandelijkse nieuwsoverzicht, de NVC Members-only Update. Heeft u vragen, neem dan contact met ons op via e-mail of bel: +31-(0)182-512411.